Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis

Int J Antimicrob Agents. 2024 Jun;63(6):107167. doi: 10.1016/j.ijantimicag.2024.107167. Epub 2024 Apr 4.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Acinetobacter Infections* / drug therapy
  • Acinetobacter Infections* / microbiology
  • Acinetobacter baumannii* / drug effects
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Carbapenems* / pharmacology
  • Carbapenems* / therapeutic use
  • Cefiderocol*
  • Cephalosporins* / pharmacology
  • Cephalosporins* / therapeutic use
  • Humans
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Cefiderocol
  • Carbapenems
  • Cephalosporins